Clinical trials
Completed Mastocytosis, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blueprint Medicines Corporation | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| Novartis Pharmaceuticals | 3 |
| Jason Robert Gotlib | 2 |
| M.D. Anderson Cancer Center | 2 |
| University Hospital, Toulouse | 2 |
| AB Science | 1 |
| Adelphi Values LLC | 1 |
| Allakos Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mastocytosis, Systemic | 26 |
| Leukemia, Mast-Cell | 10 |
| Mastocytosis | 7 |
| Mastocytosis, Cutaneous | 3 |
| Hypereosinophilic Syndrome | 2 |
| Leukemia | 2 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 |
| Mast Cell Activation Disorders | 2 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 |
| Burkitt Lymphoma | 1 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.